US manager eyes strong Nordic interest for its new biotech 2.0 fund
BNY Mellon Investment Management has launched a fund seeking to benefit from the growing gene therapy treatment market. The asset manager's director of Nordic distribution Viktoria von Kunow has high regional hopes for the new thematic fund.
When the Covid-19 pandemic hit, impact investment boutique Blueorchard designed a fund supporting entrepreneurs in developing markets battered by the virus. AMWatch quizzes the firm's impact chief about the Covid-19 fund and the growing impact rivalry among managers.